Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Lipoxen PLC (LSE?) is a biopharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and oncology drugs. Potential products, which address markets in excess of US$1 billion, currently under development include improved formulations of important biologicals including EPO, G-CSF, insulin and Interferon-alpha based on Lipoxen’s proprietary PolyXen® technology. This technology is designed to improve the stability, biological half-life and immunologic characteristics of therapeutic proteins ( www.lipoxen.com )
Lipoxen Plc
2 Royal College Street
London NW1 0NH
United Kingdom
Tel: +44 20 7691 3583
Fax: +44 20 7419 4653